Related Experiment Video
Updated: Jun 16, 2026
06:55
Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
Dose-response analyses using restricted cubic spline functions in public health research
Loic Desquilbet1, François Mariotti
1AgroParisTech, UMR 1290 BIOGER-CPP, F-75005 Paris, France. ldesquilbet@vet-alfort.fr
Statistics in Medicine
|January 21, 2010
Summary
Restricted cubic splines (RCS) offer a superior alternative to categorizing continuous exposures in regression models. This study introduces an SAS macro to implement RCS, improving dose-response association analysis and reducing confounding.
Area of Science:
- Epidemiology
- Biostatistics
- Statistical Software
Background:
- Categorizing continuous exposures in regression models can obscure non-linear dose-response relationships.
- Restricted cubic splines (RCS) are effective for characterizing, visualizing, and testing non-linear associations.
- Existing SAS software has limited implementation for RCS functions.
Purpose of the Study:
- To develop and present an SAS macro for implementing restricted cubic splines (RCS) in regression analysis.
- To facilitate the characterization and visualization of dose-response associations between continuous exposures and outcomes.
- To provide statistical tests for assessing overall and non-linear associations within various regression models.
Main Methods:
- Developed an SAS macro to create RCS functions for continuous exposures.
- Integrated the macro with linear, logistic, and Cox models, including generalized estimating equations.
- Generated graphs with 95% confidence intervals and statistical tests for dose-response relationships.
Main Results:
- The SAS macro successfully creates RCS functions and visualizes dose-response associations.
- The macro provides statistical tests for overall and non-linear effects.
- Demonstrated utility with real-world data on calcium, folate, and cholesterol in relation to health outcomes.
Conclusions:
- The developed SAS macro effectively implements restricted cubic splines for analyzing continuous exposure-outcome relationships.
- This tool enhances the ability to detect and quantify non-linear associations, improving epidemiological and clinical research.
- The macro offers a valuable solution for researchers using SAS to address limitations in handling continuous exposures.
Related Concept Videos
01:03Dose-Response Relationship: Overview
Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...
01:21Dose Response Curve: Conventional Versus Nonmonotonic
The correlation between a drug's dosage and its impact on a biological system is a cornerstone of pharmacology and toxicology. Conventional dose–response curves, which include graded and quantal relationships, are key to this understanding. Graded dose–response curves depict the spectrum of a biological reaction to different doses within an individual, indicating that as the drug dosage increases, so does the intensity of the response. On the other hand, quantal dose–response relationships...
01:12Analysis of Population Pharmacokinetic Data
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
01:22Dose-Response Relationship: Potency and Efficacy
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it produces...
01:25Dose-Response Relationship: Selectivity and Specificity
Drugs exert their therapeutic effects by interacting with receptors, enzymes, or ion channels that are present throughout the human body. The strength and duration of the interaction between a drug and its target receptor are characterized by the selectivity and specificity of the drug. Selectivity refers to a drug's strong preference for its intended target over other targets. For instance, isoprenaline, a non-selective β-adrenergic agonist, interacts with both β1- and β2-adrenergic receptors...
01:28Pharmacokinetic–Pharmacodynamic Relationship: Dose to Pharmacological Effect
A drug’s dosage and pharmacokinetic properties determine how quickly it acts, how intense its effects are, and how long it lasts. Higher doses increase drug concentration at receptor sites, producing a hyperbolic curve when pharmacologic response is plotted against drug dose. Converting this scale to a log-linear format results in a sigmoidal curve, better representing dose–response relationships.For drugs following a one-compartment model, the pharmacologic response is directly proportional to...